BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 9:05:00 AM | Browse: 1268 | Download: 1405
 |
Received |
|
2013-02-17 13:57 |
 |
Peer-Review Started |
|
2013-02-18 08:51 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-03-18 09:36 |
 |
Revised |
|
2013-03-25 23:09 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-04-10 16:55 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-04-11 05:13 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-05-15 17:18 |
 |
Publish the Manuscript Online |
|
2013-06-06 10:41 |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Editorial |
| Article Title |
Uric acid and chronic kidney disease: A time to act?
|
| Manuscript Source |
|
| All Author List |
Gianni Bellomo |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gianni Bellomo, MD, Department of Nephrology, San Giovanni Battista Hospital, Via Arcamone 1, 06034 Foligno, Italy. assidial@tin.it |
| Key Words |
Uric acid; Urate; Chronic kidney disease; Allopurinol; Febuxostat; Diabetes; Renal transplantation |
| Core Tip |
The evidence presented so far, derived from experimental, epidemiological, and a few, small, intervention studies, points towards a role for uric acid in the progression of chronic kidney disease and deterioration of renal function. However, conclusive proof, such as that coming from a randomized clinical trial, is lacking. Finally we will briefly discuss the challenges of a trial of uric-acid-lowering treatment, and the recent suggestions on how to conduct such a trial. |
| Publish Date |
2013-06-06 10:41 |
| Citation |
Bellomo G. Uric acid and chronic kidney disease: A time to act? World J Nephrol 2013; 2(2): 7-25 |
| URL |
http://www.wjgnet.com/2220-6124/full/v2/i2/17.htm |
| DOI |
http://dx.doi.org/10.5527/wjn.v2.i2.17 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.